Attached files
| file | filename |
|---|---|
| EX-10.2 - LICENSE AND COLLABORATION AGREEMENT - ClearPoint Neuro, Inc. | ex10-2.htm |
| EX-31.2 - CERTIFICATION OF CFO - ClearPoint Neuro, Inc. | ex31-2.htm |
| EX-31.1 - CERTIFICATION OF CEO - ClearPoint Neuro, Inc. | ex31-1.htm |
| EX-10.3 - DISTRIBUTION AGREEMENT - ClearPoint Neuro, Inc. | ex10-3.htm |
| 10-Q - 10-Q FILING - ClearPoint Neuro, Inc. | f18-1268.htm |
Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND
CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14(b) UNDER
THE SECURITIES EXCHANGE ACT OF 1934 AND SECTION 1350 OF
CHAPTER 63 OF TITLE 18 OF THE UNITED STATES CODE
Each of the undersigned, Joseph M. Burnett and Harold A. Hurwitz, certifies pursuant to Rule 13a-14(b) under the Securities Exchange Act of 1934 and Section 1350 of Chapter 63 of Title 18 of the United States Code, that (1) this quarterly report on Form 10-Q for the quarter ended September 30, 2018, of MRI Interventions, Inc. (the “Company”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in this quarterly report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: November 13, 2018
| /s/ Joseph M. Burnett | |
| Joseph M. Burnett | |
| Chief Executive Officer | |
| /s/ Harold A. Hurwitz | |
| Harold A. Hurwitz | |
| Chief Financial Officer |